Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Analytical chemistry

In the context of the recent pandemic, the necessity of inexpensive and easily accessible rapid-test kits is well understood and need not be stressed further. In light of this, we report a multi-nucleotide probe-based diagnosis of SARS-CoV-2 using a bioelectronics platform, comprising low-cost chemiresistive biochips, a portable electronic readout, and an Android application for data acquisition with machine-learning-based decision making. The platform performs the desired diagnosis from standard nasopharyngeal and/or oral swabs (both on extracted and non-extracted RNA samples) without amplifying the viral load. Being a reverse transcription polymerase chain reaction-free hybridization assay, the proposed approach offers inexpensive, fast (time-to-result: ≤ 30 min), and early diagnosis, as opposed to most of the existing SARS-CoV-2 diagnosis protocols recommended by the WHO. For the extracted RNA samples, the assay accounts for 87 and 95.2% test accuracies, using a heuristic approach and a machine-learning-based classification method, respectively. In case of the non-extracted RNA samples, 95.6% decision accuracy is achieved using the heuristic approach, with the machine-learning-based best-fit model producing 100% accuracy. Furthermore, the availability of the handheld readout and the Android application-based simple user interface facilitates easy accessibility and portable applications. Besides, by eliminating viral RNA extraction from samples as a pre-requisite for specific detection, the proposed approach presents itself as an ideal candidate for point-of-care SARS-CoV-2 diagnosis.

Tripathy Suryasnata, Supraja Patta, Mohanty Swati, Sai Vallepu Mohan, Agrawal Tushant, Chowdary Ch Gajendranath, Taranikanti Madhuri, Bandaru Rajiv, Mudunuru Aswin Kumar, Tadi Lakshmi Jyothi, Suravaram Swathi, Siddiqui Imran Ahmed, Maddur Srinivas, Guntuka Rohith Kumar, Singh Ranjana, Singh Vikrant, Singh Shiv Govind

2021-Oct-25